Literature DB >> 26267001

The words of pain in complex regional pain syndrome.

Roberto Casale1, Fabiola Atzeni2, Ignazio Francesco Masala3, Piercarlo Sarzi-Puttini4.   

Abstract

Complex regional pain syndrome (CRPS) encompasses a wide range of painful conditions, but it is characterised by continuing (spontaneous and/or evoked) limb pain that is seemingly disproportionate in time or degree to the usual course of any known trauma or other lesion. The pain is regional, with distal predominance usually but not related to a specific nerve territory or dermatome, and it is usually associated with abnormal sensory, motor, sudomotor, vasomotor and/or trophic findings. The complexity of the aetiopathogenetic factors making up the clinical picture of CRPS is mirrored by the inconsistency of almost all of the monotherapies used to treat it so far. Motor and sensory symptoms significantly interfere with the patients' daily function and quality of life, and almost all of them report substantial disability in their working and recreational activities, mood and mobility.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complex regional pain syndrome; Disability; Pain; Therapy

Mesh:

Year:  2015        PMID: 26267001     DOI: 10.1016/j.berh.2015.04.032

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  3 in total

Review 1.  Management of patients with complex regional pain syndrome type I.

Authors:  D Gatti; M Rossini; S Adami
Journal:  Osteoporos Int       Date:  2016-02-29       Impact factor: 4.507

2.  Complex regional pain syndrome type II caused by iatrogenic lateral dorsal cutaneous nerve injury: A case report.

Authors:  Tae-Hoon Kim; Geun-Yeol Jo; Wanil Kim; Hwan-Kwon Do
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817

3.  Complex regional pain syndrome type II after cervical transforaminal epidural injection: A case report.

Authors:  Gi-Young Park; Dong Rak Kwon; Dae Gil Kwon
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.